Specialties
Reports that name this provider
- Chemotherapy & Immunotherapy Quality in India
- Spinoff of IIT Bombay; developed NexCAR19 in collaboration with Tata Memorial Hospital and US National Cancer Institute; treated over 350 cancer patients as of 2024; achieved profitability; manufacturing capacity targeting 1,200 patients annually